Company Profile

Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Companyâ€™s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Companyâ€™s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.

Employees

1,000

Sector

Advanced Medical Equipment & Technology

More about the company

03-26	Altivera Medical Holdings, LLC acquired Zynex, Inc.	CI
03-26	Zynex, Inc. Secures Term Loan Credit Agreement Finalized	CI
03-26	Zynex, Inc. Emerged from Bankruptcy	CI
03-20	Court confirms Zynex plan of reorganization on March 19, 2026 - SEC filing	RE
03-19	Third Amended Reorganization Plan Approved for Zynex, Inc.	CI
02-19	Zynex Inc says SEC concluded investigation into Zynex, no enforcement action planned	RE
02-17	Zynex Inc resolves federal investigation into business practices	RE
02-09	Notice of Auction Cancellation and Designation of Successful Bidder Filed by Zynex, Inc.	CI
02-06	Third Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
02-04	Zynex, Inc. Announces New In-Network Provider Status with Humana	CI
02-01	Second Amended Joint Disclosure Statement Conditionally Approved and Combined Hearing of Second Amended Disclosure Statement and Reorganization Plan Approved for Zynex, Inc.	CI
01-31	Second Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI
01-28	First Amended Combined Joint Reorganization Plan and Disclosure Statement Filed by Zynex, Inc.	CI

25-08-01	RBC Capital Adjusts Price Target on Zynex to $2 From $3, Maintains Sector Perform Rating	MT
25-08-01	HC Wainwright Downgrades Zynex to Neutral From Buy	MT
25-07-31	Medtech Zynex's Q2 revenue falls more than expected, names new CEO, suspends forecast	RE
25-07-15	RBC Cuts Price Target on Zynex to $3 From $4, Keeps Sector Perform Rating	MT
25-04-30	RBC Cuts Price Target on Zynex to $4 From $5, Keeps Sector Perform Rating	MT

03-27	ZYXIQ Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
03-26	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR
03-26	ZYXIQ SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Zynex (ZYXIQ) Investors of Securities Class Action Deadline on April 21, 2026	NE
03-25	Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of April 21, 2026 in Zynex, Inc. Lawsuit - ZYXIQ	PR
03-24	ZYXI SHAREHOLDER UPDATE: Hagens Berman Alerts Zynex (ZYXI / ZYXIQ) Investors to Securities Class Action Following Bankruptcy and Federal Fraud Settlements	PR

22-12-27	Top 50 Small-caps 2023
22-12-21	Top 50 Small-caps 2023
21-10-21	Los valores del Nasdaq con mayor crecimiento
21-10-21	Les actions du Nasdaq avec la plus forte croissance

1 day	+5.77%
Current year	-56.35%

Zynex, Inc. Stock

Stocks

ZYXI

US98986M1036

Advanced Medical Equipment & Technology

Chart: Zynex, Inc.

Latest news: Zynex, Inc.

Last Transcript: Zynex, Inc.

Analysts' recommendations: Zynex, Inc.

Press Releases: Zynex, Inc.

News in other languages: Zynex, Inc.

Quotes and Performance

Price Extremes

Managers and Directors: Zynex, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Company Profile

Current year	0.02	0.13
1 year	0.02	2.1
3 years	0.02	13.77
5 years	0.02	17.25
10 years	0.02	27.02

Manager	Title	Age	Since
Steven Dyson CEO	Chief Executive Officer	53	2025-08-17
Vikram Bajaj DFI	Director of Finance/CFO	50	2025-08-17
John Bibb LAW	General Counsel	53	2025-08-17

Director	Title	Age	Since
Vikram Bajaj BRD	Director/Board Member	50	2026-03-25
John Bibb BRD	Director/Board Member	53	2026-03-25

Date	Insider	Type	Main position	Quantity	% Market Cap.
3/26/26	Barry Michaels	Issuer sale	Director	80,001	0.2633%
3/26/26	Michael Cress	Issuer sale	Director	95,000	0.3126%
3/26/26	Joshua Disbrow	Issuer sale	Director	102,000	0.3357%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ZYNEX, INC.	+5.77%	-.--%	-	-	1.69M
THERMO FISHER SCIENTIFIC, INC.	+2.63%	-0.32%	+22.75%	+52.69%	251B
INTUITIVE SURGICAL, INC.	-3.36%	+4.81%	-17.34%	+63.31%	162B
DANAHER CORPORATION	+1.73%	-0.85%	+9.29%	+17.76%	159B
BOSTON SCIENTIFIC CORPORATION	-4.23%	+1.83%	-56.84%	-19.05%	64.7B
EDWARDS LIFESCIENCES CORPORATION	+1.31%	+11.01%	+23.90%	+52.22%	57.97B
SIEMENS HEALTHINEERS AG	-0.76%	+4.13%	-0.76%	-6.92%	56.21B
VEEVA SYSTEMS INC.	-2.05%	-2.95%	+4.30%	+54.85%	50.21B
AGILENT TECHNOLOGIES, INC.	+1.73%	-0.06%	+18.49%	+62.52%	48.43B
WATERS CORPORATION	+1.00%	-1.11%	+23.29%	+81.48%	44.51B
Average	+0.38%	+1.45%	+3.01%	+39.87%	99.39B
Weighted average by Cap.	+0.19%	+1.29%	+4.68%	+41.52%